PATH, Mologic to Develop Malaria Rapid Diagnostic Test

Apr 17, 2018

NEW YORK (360Dx) – Mologic and PATH said today that they have entered an agreement to advance a new rapid diagnostic test (RDT) to support treating and eliminating Plasmodium vivax malaria.

PATH, an international nonprofit with a focus on improving health, especially among women and children, is supporting Mologic in commercializing the RDT and obtaining regulatory approvals.

Financial and other terms of the agreement were not disclosed.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Featured White Papers

Advancing Patient Care and Aiding Diagnosis at the Point of Care

Molecular Tests Provide a Better Alternative to Stool Culture for GI Cases

Feb

26

Featured Webinar

A Cellular and Molecular Phenotyping Pipeline for Target Characterization in FFPE Biobank Samples

This webinar will demonstrate how a research team at the Firestone Institute for Respiratory Health at McMaster University developed a cellular and molecular phenotyping pipeline using archived samples of lung tissue derived from patients diagnosed with fibrotic interstitial lung disease.

Mar

19

Featured Webinar

One Test May Not Fit All: Evaluation of Point-of-Care Assays for Influenza Testing

In this webinar, Dr. Matthew Faron, a pathologist from the Medical College of Wisconsin, will share results of a comparison study of three rapid influenza assays.

Mar

20

Featured Webinar

A New Multiplex Syndromic System For Respiratory Diagnosis And Improved Patient Care

This webinar will discuss how a new multiplexed testing system can help physicians rapidly diagnose acute respiratory infections in the near-patient setting.

Mar

27

Featured Webinar

How One NGS Core Lab Reduced Sequencing Costs with a Novel Library Normalization Kit

Sequencing workflows require library quantification and normalization to ensure data quality and reduce cost.

Main menu